Cost effectiveness of implementing ESC guidelines for treatment of iron deficiency in heart failure in the Nordic countries

References

• McMurray JJ, Pfeffer MA. Heart failure. Lancet. 2005;365:1877–1889.
   PubMed Web of Science ®Google Scholar
• Zarrinkoub R, Wettermark B, Wandell P, et al. The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden. Eur J Heart Fail. 2013;15:995–1002.
   PubMed Web of Science ®Google Scholar
• Cannon JA, Moffitt P, Perez-Moreno AC, et al. Cognitive impairment and heart failure: systematic review and meta-analysis. J Card Fail. 2017;23:464–475.
   PubMed Web of Science ®Google Scholar
• Hobbs FD, Kenkre JE, Roalfe AK, et al. Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J. 2002;23:1867–1876.
   PubMed Web of Science ®Google Scholar
• Ambrosy AP, Fonarow GC, Butler J, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014;63:1123–1133.
   PubMed Web of Science ®Google Scholar
• Braunschweig F, Cowie MR, Auricchio A. What are the costs of heart failure? Europace. 2011;13:ii13–ii17.
   PubMed Web of Science ®Google Scholar
• Jankowska EA, Rozentryt P, Witkowska A, et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J. 2010;31:1872–1880.
   PubMed Web of Science ®Google Scholar
• Klip IT, Comin-Colet J, Voors AA, et al. Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J. 2013;165:575–582 e3.
   PubMed Web of Science ®Google Scholar
• McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33:1787–1847.
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891–975.
   PubMed Web of Science ®Google Scholar
• Anker SD, Comin Colet J, Filippatos G, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361:2436–2448.
   PubMed Web of Science ®Google Scholar
• Comin-Colet J, Rubio-Rodriguez D, Rubio-Terres C, et al. A Cost-Effectiveness Analysis of Ferric Carboxymaltose in Patients with Iron Deficiency and Chronic Heart Failure in Spain. Rev Esp Cardiol (Engl Ed). 2015;68:846–851.
   PubMed Web of Science ®Google Scholar
• Gutzwiller FS, Schwenkglenks M, Blank PR, et al. Health economic assessment of ferric carboxymaltose in patients with iron deficiency and chronic heart failure based on the FAIR-HF trial: an analysis for the UK. Eur J Heart Fail. 2012;14:782–790.
   PubMed Web of Science ®Google Scholar
• Hofmarcher T, Borg S. Cost-effectiveness analysis of ferric carboxymaltose in iron-deficient patients with chronic heart failure in Sweden. J Med Econ. 2015;18:492–501.
   PubMed Web of Science ®Google Scholar
• Ponikowski P, van Veldhuisen DJ, Comin-Colet J, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J. 2015;36:657–668.
   PubMed Web of Science ®Google Scholar
• Drummond M. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005.
   Google Scholar
• Purchasing power parities (PPPs), price level indices and real expenditures for ESA 2010 aggregates [prc_ppp_ind] [Internet]. Luxembourg: Eurostat; [February 2, 2018]. Available from: http://ec.europa.eu/eurostat/data/database
   Google Scholar
• Helsedirektoratet. Innsatsstyrt Finansiering 2017 [Investment-based funding 2017]. Oslo: Helsedirektoratet, 2016.
   Google Scholar
• Kapiainen S, Väisänen A, Haula T. Terveyden- ja Sosiaalihuollon Yksikkökustannukset Suomessa Vuonna 2011 [Unit Costs of Health and Social Care in Finland in 2011]. Tampere: Terveyden ja hyvinvoinnin laitos, 2014.
   Google Scholar
• Region Skåne Medicinsk service - Labmedicin - Pris 2017 - Klinisk Kemi [Medical Service - Laboratory Medicine - Price 2017 - Clinical Chemistry]. Lund/Malmö: Region Skåne, 2016.
   Google Scholar
• Sundhedsdatastyrelsen. Takstsystem 2017 - Vejledning [Tariff System 2017 - Guidance]. Copenhagen: Sundhedsdatastyrelsen, 2016.
   Google Scholar
• Södra Regionvårdsnämnden Regionala Priser Och Ersättningar För Södra Sjukvårdsregionen 2017 [Regional Prices and Compensation for the Southern Health Care Region 2017]. Lund/Malmö: Södra Regionvårdsnämnden, 2016.
   Google Scholar
• HICP (2015 = 100) - Annual Data (average Index and Rate of Change) [Prc_hicp_aind] [Internet]. Luxembourg: Eurostat; [February 2, 2018]. Available from: http://ec.europa.eu/eurostat/data/database
   Google Scholar
• Euro foreign exchange reference rates [Internet]. Frankfurt: European Central Bank; [March 8, 2018]. Available from: http://www.ecb.europa.eu/stats/policy_and_exchange_rates/euro_reference_exchange_rates/html/index.en.html
   Google Scholar
• Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35:1095–1108.
   PubMed Web of Science ®Google Scholar
• Maggioni AP, Van Gool K, Biondi N, et al. Appropriateness of prescriptions of recommended treatments in organisation for economic co-operation and development health systems: findings based on the long-term registry of the European Society of Cardiology on Heart Failure. Value Health. 2015;18:1098–1104.
   PubMed Web of Science ®Google Scholar
• Thorvaldsen T, Benson L, Dahlstrom U, et al. Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012. Eur J Heart Fail. 2016;18:503–511.
   PubMed Web of Science ®Google Scholar
• Drozd M, Jankowska EA, Banasiak W, et al. Iron therapy in patients with heart failure and iron deficiency: review of iron preparations for practitioners. Am J Cardiovasc Drugs. 2017;17:183–201.
   PubMed Web of Science ®Google Scholar
• Lewis GD, Malhotra R, Hernandez AF, et al. Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: The IRONOUT HF Randomized Clinical Trial. JAMA. 2017;317:1958–1966.
   PubMed Web of Science ®Google Scholar
• Kompetencecenter for Klinisk Kvalitet og Sundhedsinformatik Vest. Dansk Hjertesvigtdatabase - Årsrapport 2014 - Version 1.1 [Danish Heart Failure Database - Annual Report 2014 - Version 1.1]. Aarhus: Kompetencecenter for Klinisk Kvalitet og Sundhedsinformatik Vest, 2015.
   Google Scholar
• Nasjonalt sekretariat for Norsk hjertesviktregister. Norsk hjertesviktregister - Årsrapport 2016 [Norwegian Heart Failure Register - Annual Report 2016]. Trondheim: Nasjonalt sekretariat for Norsk hjertesviktregister, 2017.
   Google Scholar
• Vasko P, Jonsson Å, Dahlström U, et al. Årsrapport RiksSvikt - 2015 års resultat [Annual Report SwedeHF - 2015 results]. 2017.
   Google Scholar
• Agvall B, Borgquist L, Foldevi M, et al. Cost of heart failure in Swedish primary healthcare. Scand J Prim Health Care. 2005;23:227–232.
   PubMed Web of Science ®Google Scholar
• Anker SD, Kirwan BA, van Veldhuisen DJ, et al. Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis. Eur J Heart Fail. 2018;20:125–133.
   PubMed Web of Science ®Google Scholar